期刊文献+

靶向表皮生长因子受体基因的短发夹RNA对肺腺癌A549细胞生长及药物敏感性的影响

Effects of transient transfection of short hairpin RNA targeting EGFR into lung adenocarcinoma A549 cell line on cell growth and sensitivity to cytotoxic drugs
原文传递
导出
摘要 目的探讨瞬时转染靶向表皮生长因子受体(EGFR)基因的短发夹RNA(shRNA)表达载体对肺腺癌A549细胞生长及药物敏感性的影响。方法构建靶向EGFR的shRNA载体(pShEGFR)和非特异性的shRNA载体(pShNEG),阳离子脂质体将其转染至肺腺癌A549细胞,免疫荧光和Western blot法检测转染后细胞中EGFR蛋白表达变化;克隆形成实验观察细胞生长变化;流式细胞仪检测细胞周期和凋亡;MTI法检测细胞对顺铂、阿霉素、泰素的敏感性。结果与未转染组和pShNEG转染组细胞相比,pShEGFR可显著抑制A549细胞中EGFR蛋白表达,转染后第6天抑制率达74.1%(P<0.01);pShEGFR转染组细胞克隆形成抑制率为62.8%。与未转染组和pShNEG组相比,pShEGFR组细胞阻滞在G_0/G_1期(P<0.01),凋亡细胞比例显著增加(P<0.01);与未转染组相比,pShEGFR可将A549细胞对顺铂、阿霉素、泰素的敏感性分别提高6.7、5.5、6.6倍。结论瞬时转染靶向EGFR基因的shRNA表达载体能够通过下调EGFR蛋白水平抑制肺腺癌A549细胞生长,并提高细胞对不同化疗药物的敏感性。 Objective To determine the effects of vector-based short hairpin RNA (shRNA) targe-ting EGFR on cell growth and sensitivity to cytotoxic drugs in lung adenocarcinoma A549 cell line. Methods Vector-based short hairpin RNA targeting EGFR (pShEGFR) and negative control shRNA (pShNEG) were respectively transfected into A549 cells. The protein level of EGFR was observed by immunofluores-cence, and then further quantified by Western blot. The effect of shRNA targeting EGFR on tumor cell growth was assessed by colony formation assay, cell cycle and apoptosis by flow cytometry, and the sensitivity of A549 to cytotoxie drugs by 3- [ 4,5-dimethylthiozol-2 yl ] -2,5-diphenyhetrazolium bromide [ MTT] assay. Results Vectors expressing shRNA against EGFR significantly down-regulated the receptor expression by 74.1% on day 6 after transfection and the colony number by 62.8% in A549 ( P 〈 0.01 ). Vector-based shRNA against EGFR caused G1 arrest, induced apoptosis, and subsequently increased the sensitivity to eisplatin, doxorubicin and paclitaxel by 6.7, 5.5, 6.6 fold in A549, respectively ( P 〈 0. 01 ). Conclusion Vector-based shRNA may effectively inhibit the growth and enhance the sensitivity of A549 cells to cytotoxic drugs through downregulation of EGFR gene expression.
出处 《中华肺部疾病杂志(电子版)》 CAS 2007年第1期12-15,共4页 Chinese Journal of Lung Diseases(Electronic Edition)
基金 中国博士后科学基金资助项目(2005037488) 上海市科委重大科技攻关项目(04DZ19208)
关键词 表皮生长因子 短发夹 RNA 肺肿瘤 抗药性 EGFR shRNA Lung carcinoma Drug resistance
  • 相关文献

参考文献13

  • 1Fischer L.TAN,James Q.YIN.RNAi,a new therapeutic strategy against viral infection[J].Cell Research,2004,14(6):460-466. 被引量:15
  • 2罗红,范寒桂,陈贵芹.硅胶环管支撑泪小管断裂吻合术[J].眼外伤职业眼病杂志,2001,23(4):430-431. 被引量:37
  • 3José Baselga.Monoclonal Antibodies Directed at Growth Factor Receptors[J].Annals of Oncology.2000(3)
  • 4Ciardiello F,Tortora G.Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs[].European Journal of Cancer.2003
  • 5Verma NK,Dey CS.RNA-mediated gene silencing: mechanisms and its therapeutic applications[].Journal of Clinical Pharmacy and Therapeutics.2004
  • 6Jen K Y,Gewirtz A M.Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies[].Stem Cells.2000
  • 7Wakeling A E.Epidermal growth factor receptor tyrosine kinase inhibitors[].Current Opinion in Pharmacology.2002
  • 8Hannon GJ.RNA interference[].Nature.2002
  • 9Rye PD,Stigbrand T.Interfering with cancer: a brief outline of advances in RNA interference in oncology[].Tumour Biology.2004
  • 10Ciardiello F,Caputo R,Bianco R,et al.Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor[].Clinical Cancer Research.2000

二级参考文献62

  • 1易明望,罗红,黎家国.泪小管断裂吻合术(附12例报告)[J].湖北医科大学学报,1994,15(1):87-88. 被引量:19
  • 2田振兰,王利华,张存福.环管支撑泪小管断端吻合术探讨[J].中国实用眼科杂志,1995,13(1):48-49. 被引量:12
  • 3[1]Fire A, Xu S, Montgomery MK, et al. Potent and specific genetics interference by double-stranded RNA in Caenorhabitis elegans. Nature 1998; 391:806-11.
  • 4[2]Jorgensen R. Altered gene expression in plants due to trans interactions between homologous genes. Trends Biotechnol 1990; 8:340-4.
  • 5[3]Romano N, Macino G. Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences. Mol Microbiol 1992; 6: 3343-53.
  • 6[4]Dave RS, Pomerantz RJ. RNA interference: on the to an to alternate therapeutic strategy. Rev Med Virol 2003; 13: 373-85.
  • 7[5]Plasterk RA. RNA silencing: the genome's immune system.Science, 2002; 296: 1263-5.
  • 8[6]Yin JQ, Wan Y. siRNA-mediated gene regulation system. Int J Mol Med 2002; 10:355-65.
  • 9[7]Yin JQ, Cao JS, Shao RG, et al. SiRNA agents inhibit oncogene expression and attenuate human tumor cell growth. J Exp Ther Onc 2003; 3:1-11.
  • 10[8]Liu TG, Yin JQ, Shang BY, et al. Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer. Cancer Gene Therapy (In Press).

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部